As the United States government still tries to tell its people that cannabis is one of the most dangerous and addictive drugs in the world, there has been a sign from Washington D.C. that could indicate that the federal government’s fight against marijuana could begin to die down.
It looks as though the United States Food and Drug Administration (FDA) is observing Canada in order to learn how to properly legalize and manage medical marijuana. A new report from marijuana.com shows that the health agency has been assembled in order to observe all of the cannabis policies that are being established later on in June so that they can get an idea of the “regulatory framework for the regulation of marijuana for medicinal purposes,” and “information on the licensing process, compliance and enforcement and market statistics.”
This seems as though it is good news, but in reality, nobody completely knows why the FDA is interested in Canada’s legalization process. However, there are many that believe it will be related to a rescheduling announcement that is going to come from the U.S. Drug Enforcement Administration (DEA) at the end of June. Most of the powerful leaders of the federal government have said that they will not consider rescheduling the drug until the FDA gives informs them that they should. That recommendation was given by the FDA last September.
“The fact that FDA is taking a close look at how the Canadian federal government legally regulates medical cannabis could be a sign that the Obama administration is preparing to announce a big change in policy soon,” Tom Angell, chairman of the Marijuana Majority, said. “But it might also just be the agency doing its due diligence to begin preparing for changes that seem inevitable at some point in the near- to mid-term future.”
